Equities

Inmode Ltd

Inmode Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)17.72
  • Today's Change0.26 / 1.49%
  • Shares traded2.84k
  • 1 Year change-47.47%
  • Beta2.1750
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy1
Outperform1
Hold4
Sell0
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Inmode Ltd have a median target of 20.00, with a high estimate of 29.00 and a low estimate of 16.00. The median estimate represents a 12.74% increase from the last price of 17.74.
High63.5%29.00
Med12.7%20.00
Low-9.8%16.00

Earnings history & estimates in USD

On Aug 01, 2024, Inmode Ltd reported 2nd quarter 2024 earnings of 0.34 per share.
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate-11.89%
Inmode Ltd reported annual 2023 earnings of 2.57 per share on Feb 13, 2024.
Average growth rate+37.61%
More ▼

Revenue history & estimates in USD

InMode Ltd. had 2nd quarter 2024 revenues of 86.45m. This missed the 101.67m consensus estimate of the 6 analysts following the company. This was 18.50% below the prior year's 2nd quarter results.
Average growth rate-8.89%
InMode Ltd. had revenues for the full year 2023 of 492.05m. This was 8.32% above the prior year's results.
Average growth rate+35.17%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.